Srijita Chakrabarti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Srijita Chakrabarti has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Anmoy Nandi
Faculty of Pharmaceutical Science, Assam down town University, Sankar Madhab Path, Gandhi Nagar, Panikhaiti, Guwahati, Assam, PIN, 781026, India
3 shared publications- Manash Pratim Pathak
Faculty of Pharmaceutical Science, Assam down town University, Panikhaiti, Guwahati, India
2 shared publications - Pervej Alom Barbhuiya
Faculty of Pharmaceutical Science, Assam down town University, Panikhaiti, Guwahati, India
2 shared publications - Punam Kumari
Faculty of Pharmaceutical Science, Assam down town University, Panikhaiti, Guwahati, India
2 shared publications Soutik Sarkar
2 shared publications- Ameena Ahmed
Faculty of Pharmaceutical Science, Assam down town University, Panikhaiti, Guwahati, India
1 shared publication
Latest Publications
- 24 September 2026
- Published by Springer Nature in Polymer Bulletin
- Vol. 83 (12) , 643
Next-generation bioactive polymeric patches for chronic wound healing: from advanced architectures to translational challenges
- 24 September 2026
- Published by Springer Nature in Polymer Bulletin
- Vol. 83 (12) , 643
Next-generation bioactive polymeric patches for chronic wound healing: from advanced architectures to translational challenges
- 2 July 2026
- Published by Bentham Science Publishers Ltd. in Recent Advances in Drug Delivery and Formulation
- Vol. 20, 1-11
Advances in Microemulsion Drug Delivery: From Fundamentals to Therapeutic Applications
Microemulsion-based drug delivery systems are increasingly attracting attention in the pharmaceutical field owing to their remarkable capacity to enhance solubility, stability, and bioavailability, as well as enable targeted drug delivery. These systems comprise clear, stable, isotropic blends of oil, water, and surfactant, often accompanied by a co-surfactant. Their appeal to pharmaceutical scientists lies in their versatility as effective drug-delivery vehicles, accommodating a diverse array of drug molecules. Microemulsions have demonstrated effectiveness in protecting fragile drugs, controlling drug release, enhancing solubility, increasing bioavailability, and reducing variation in patient response. Moreover, formulations suitable for various routes of administration have been successfully devised. Since their discovery, microemulsions have gained prominence, becoming increasingly vital in both academic research and industrial settings due to their distinct characteristics, such as reduced interfacial tension, extensive interfacial area, thermodynamic stability, and the ability to solubilize otherwise immiscible substances. Transparent appearance, low viscosity, and inherent thermodynamic stability set microemulsions apart from conventional emulsions. This review aims to elucidate the potential of microemulsions as delivery vehicles and to provide insights into their formation principles. Additionally, it comprehensively explores microemulsion-based drug delivery systems, encompassing oral, topical, transdermal, ocular, and parenteral delivery methods, with a focus on recent advancements, existing challenges, and future trajectories.
- 2 July 2026
- Published by Bentham Science Publishers Ltd. in Recent Advances in Drug Delivery and Formulation
- Vol. 20, 1-11
Advances in Microemulsion Drug Delivery: From Fundamentals to Therapeutic Applications
Microemulsion-based drug delivery systems are increasingly attracting attention in the pharmaceutical field owing to their remarkable capacity to enhance solubility, stability, and bioavailability, as well as enable targeted drug delivery. These systems comprise clear, stable, isotropic blends of oil, water, and surfactant, often accompanied by a co-surfactant. Their appeal to pharmaceutical scientists lies in their versatility as effective drug-delivery vehicles, accommodating a diverse array of drug molecules. Microemulsions have demonstrated effectiveness in protecting fragile drugs, controlling drug release, enhancing solubility, increasing bioavailability, and reducing variation in patient response. Moreover, formulations suitable for various routes of administration have been successfully devised. Since their discovery, microemulsions have gained prominence, becoming increasingly vital in both academic research and industrial settings due to their distinct characteristics, such as reduced interfacial tension, extensive interfacial area, thermodynamic stability, and the ability to solubilize otherwise immiscible substances. Transparent appearance, low viscosity, and inherent thermodynamic stability set microemulsions apart from conventional emulsions. This review aims to elucidate the potential of microemulsions as delivery vehicles and to provide insights into their formation principles. Additionally, it comprehensively explores microemulsion-based drug delivery systems, encompassing oral, topical, transdermal, ocular, and parenteral delivery methods, with a focus on recent advancements, existing challenges, and future trajectories.
- 23 June 2026
- Published by Springer Nature in Lung
- Vol. 204 (1)
The Pleural Microenvironment in Pulmonary Injury and Fibrosis: Mechanistic Insights and Links to Tissue Repair
The pleural microenvironment has long been considered a passive anatomical boundary. However, emerging evidence identifies it as an active regulator of inflammation, tissue repair, and fibrotic remodeling. This review evaluates the mechanistic contribution of pleural mesothelial cells (PMCs) to pulmonary injury and fibrosis and explores their potential role in coordinating regenerative responses. Recent preclinical and clinical studies investigating pleural biology, mesothelial plasticity, mesothelial-mesenchymal transition (MesoMT), and pulmonary fibrosis were critically analyzed. Evidence from cutaneous wound healing was integrated to identify common molecular pathways governing tissue repair and fibrotic progression RESULTS: PMCs actively participate in pulmonary remodeling by secreting cytokines, growth factors, and extracellular matrix regulators. Persistent activation of TGF-β/Smad, Wnt/β-catenin, PI3K/Akt, and IL-6/STAT3 signaling promotes MesoMT, myofibroblast accumulation, and progressive extracellular matrix deposition in pulmonary fibrosis. Conversely, pleural-derived mediators have demonstrated regenerative potential by enhancing epithelial proliferation, migration, angiogenesis, and tissue repair in experimental models. Collectively, current evidence suggests that pleural signaling functions as a context-dependent regulatory network that influences the transition between effective regeneration and pathological fibrosis CONCLUSION: The pleura can be regarded as a dynamic signaling niche that extends beyond its traditional structural role. We propose the pleural microenvironment as a regulatory interface governing the balance between tissue regeneration and fibrotic remodeling. Targeting pleural-derived signaling networks may provide novel therapeutic opportunities for restoring physiological repair while limiting fibrotic progression in chronic lung diseases.
- 23 June 2026
- Published by Springer Nature in Lung
- Vol. 204 (1)
The Pleural Microenvironment in Pulmonary Injury and Fibrosis: Mechanistic Insights and Links to Tissue Repair
The pleural microenvironment has long been considered a passive anatomical boundary. However, emerging evidence identifies it as an active regulator of inflammation, tissue repair, and fibrotic remodeling. This review evaluates the mechanistic contribution of pleural mesothelial cells (PMCs) to pulmonary injury and fibrosis and explores their potential role in coordinating regenerative responses. Recent preclinical and clinical studies investigating pleural biology, mesothelial plasticity, mesothelial-mesenchymal transition (MesoMT), and pulmonary fibrosis were critically analyzed. Evidence from cutaneous wound healing was integrated to identify common molecular pathways governing tissue repair and fibrotic progression RESULTS: PMCs actively participate in pulmonary remodeling by secreting cytokines, growth factors, and extracellular matrix regulators. Persistent activation of TGF-β/Smad, Wnt/β-catenin, PI3K/Akt, and IL-6/STAT3 signaling promotes MesoMT, myofibroblast accumulation, and progressive extracellular matrix deposition in pulmonary fibrosis. Conversely, pleural-derived mediators have demonstrated regenerative potential by enhancing epithelial proliferation, migration, angiogenesis, and tissue repair in experimental models. Collectively, current evidence suggests that pleural signaling functions as a context-dependent regulatory network that influences the transition between effective regeneration and pathological fibrosis CONCLUSION: The pleura can be regarded as a dynamic signaling niche that extends beyond its traditional structural role. We propose the pleural microenvironment as a regulatory interface governing the balance between tissue regeneration and fibrotic remodeling. Targeting pleural-derived signaling networks may provide novel therapeutic opportunities for restoring physiological repair while limiting fibrotic progression in chronic lung diseases.
- Top Cited Papers
- 2 February 2026
- Published by Taylor & Francis in Journal of Essential Oil Research
- Vol. 38 (2) , 133-159
Advanced encapsulation techniques for essential oils: enhancing stability and bioavailability through nanocarriers
- 2 February 2026
- Published by Taylor & Francis in Journal of Essential Oil Research
- Vol. 38 (2) , 133-159
Top Cited PapersAdvanced encapsulation techniques for essential oils: enhancing stability and bioavailability through nanocarriers
- 1 November 2024
- Published by Bentham Science Publishers Ltd. in Current Nanomedicine
- Vol. 14 (3) , 169-177
Nanomedicine as a Better Therapeutic Approach: An Overview
: The fields of nanotechnology and nanomedicine have undergone a revolution. There has been a striking rise in authorized nanomedicines since 1980. Apart from functioning as thera-peutic agents, they also act as carriers for delivering various active pharmaceuticals to target or-gans. The ultimate goal of nanomedicine has always been the generation of translational technol-ogies that can improve current therapies. Nanocrystals, nanotubes, liposomes, exosomes, solid li-pid nanoparticles, polymeric nanoparticles, and metallic and magnetic nanoparticles are examples of nanostructures that are now in the market as well as in ongoing research. The preparation of these nanomaterials requires consideration of a number of difficulties. Only a few of these nano-materials were successful in obtaining marketing permission after passing all required toxicologi-cal and ethical evaluations and making them affordable to users and, at the same time, profitable to investors. Cancer, central nervous system (CNS) diseases, and cardiovascular (CVS) diseases represented the primary targets of nanotechnology applied to medicine. Therefore, this review ar-ticle is focused on providing a summary of several nano-based delivery systems, including their limitations and prospects in different therapeutic fields.
- 1 November 2024
- Published by Bentham Science Publishers Ltd. in Current Nanomedicine
- Vol. 14 (3) , 169-177
Nanomedicine as a Better Therapeutic Approach: An Overview
: The fields of nanotechnology and nanomedicine have undergone a revolution. There has been a striking rise in authorized nanomedicines since 1980. Apart from functioning as thera-peutic agents, they also act as carriers for delivering various active pharmaceuticals to target or-gans. The ultimate goal of nanomedicine has always been the generation of translational technol-ogies that can improve current therapies. Nanocrystals, nanotubes, liposomes, exosomes, solid li-pid nanoparticles, polymeric nanoparticles, and metallic and magnetic nanoparticles are examples of nanostructures that are now in the market as well as in ongoing research. The preparation of these nanomaterials requires consideration of a number of difficulties. Only a few of these nano-materials were successful in obtaining marketing permission after passing all required toxicologi-cal and ethical evaluations and making them affordable to users and, at the same time, profitable to investors. Cancer, central nervous system (CNS) diseases, and cardiovascular (CVS) diseases represented the primary targets of nanotechnology applied to medicine. Therefore, this review ar-ticle is focused on providing a summary of several nano-based delivery systems, including their limitations and prospects in different therapeutic fields.
- 16 October 2024
- Published by Elsevier in Clinical Microbiology Newsletter
- Vol. 49, 15-27
Current scenario and future prospect of scabies treatment: A comprehensive review
- 16 October 2024
- Published by Elsevier in Clinical Microbiology Newsletter
- Vol. 49, 15-27
Current scenario and future prospect of scabies treatment: A comprehensive review
- 1 September 2019
- Published by SAGE Publications in Toxicology and Industrial Health
- Vol. 35 (9) , 577-592
Exploration of cytotoxic and genotoxic endpoints following sub-chronic oral exposure to titanium dioxide nanoparticles
Health hazards of titanium dioxide nanoparticles (TiO2-NPs) have raised severe concerns because of the paucity of information regarding the toxic effects among the population. In the present research, the in vitro and in vivo cytotoxic potential of TiO2-NPs were evaluated using flow cytometric techniques. Further, in vitro and in vivo genotoxic endpoints were estimated by means of comet, micronucleus (MN), and chromosomal aberration (CA) assays. In vitro analysis was performed at the concentration range of 10–100 µg/mL using murine RAW 264.7 cells. In vivo experiments were conducted on Albino mice (M/F) by exposing them to 200 and 500 mg/kg TiO2-NPs for 90 days. Decreased percentage of cell viability with higher doses of TiO2-NPs was evident in both in vitro and in vivo flow cytometric analysis. Further, an impaired cell cycle (G0/G1, S, and G2/M) was reflected in the present investigation following the exposure to TiO2-NPs. Increased comet scores such as tail length, % DNA in tail, tail moment, and olive moment were also observed with the higher doses of TiO2-NPs in vitro and in vivo comet assays. Finally, the in vivo MN and CA assays revealed the formation of MN and chromosomal breakage following the exposure to TiO2-NPs.
- 1 September 2019
- Published by SAGE Publications in Toxicology and Industrial Health
- Vol. 35 (9) , 577-592
Exploration of cytotoxic and genotoxic endpoints following sub-chronic oral exposure to titanium dioxide nanoparticles
Health hazards of titanium dioxide nanoparticles (TiO2-NPs) have raised severe concerns because of the paucity of information regarding the toxic effects among the population. In the present research, the in vitro and in vivo cytotoxic potential of TiO2-NPs were evaluated using flow cytometric techniques. Further, in vitro and in vivo genotoxic endpoints were estimated by means of comet, micronucleus (MN), and chromosomal aberration (CA) assays. In vitro analysis was performed at the concentration range of 10–100 µg/mL using murine RAW 264.7 cells. In vivo experiments were conducted on Albino mice (M/F) by exposing them to 200 and 500 mg/kg TiO2-NPs for 90 days. Decreased percentage of cell viability with higher doses of TiO2-NPs was evident in both in vitro and in vivo flow cytometric analysis. Further, an impaired cell cycle (G0/G1, S, and G2/M) was reflected in the present investigation following the exposure to TiO2-NPs. Increased comet scores such as tail length, % DNA in tail, tail moment, and olive moment were also observed with the higher doses of TiO2-NPs in vitro and in vivo comet assays. Finally, the in vivo MN and CA assays revealed the formation of MN and chromosomal breakage following the exposure to TiO2-NPs.